The Motley Fool

Why the Auscann Group Holdings Ltd share price just rocketed 15% higher

The Auscann Group Holdings Ltd (ASX: AC8) share price has been one of the best performers on the Australian share market today.

In afternoon trade the medicinal cannabis company’s shares are up a massive 15% to 53 cents.

What happened?

This morning AusCann’s shares emerged from their trading halt following the release of a positive update on its Australian operations.

According to today’s release, AusCann has been granted a licence to manufacture medicinal cannabis in Australia.

This latest licence enables the manufacture and supply of cannabinoid medicines and completes the supply chain for the company. Previously the company had been granted cultivation licences in Western Australia and Tasmania.

Should you invest?

As this licence makes AusCann one of the first complete and fully Australian supply chains to provide medicinal cannabis products to patients, management believes it puts the company in a strong position moving forward.

And I agree. Although I’m holding off an investment in the sector until there are meaningful sales being generated, anyone looking to gain early exposure to the industry could do a lot worse than AusCann.

With all its licences in place, a strong cash balance, and royalty-free shared expertise from Canadian giant Canopy Growth Corp, I believe AusCann has as good a chance as any to succeed.

The shares of strategic partner Zelda Therapeutics Ltd (ASX: ZLD) are also higher on the news.

Finally, if it is a little too soon for you to invest in pot stocks then these hot stocks could be exactly what you need. I'm tipping them to smash the market over the next 12 months.

Top 3 ASX Blue Chips To Buy In 2017

For many, blue chip stocks mean stability, profitability and regular dividends, often fully franked..

But knowing which blue chips to buy, and when, can be fraught with danger.

The Motley Fool’s in-house analyst team has poured over thousands of hours worth of proprietary research to bring you the names of "The Motley Fool’s Top 3 Blue Chip Stocks for 2017."

Each one pays a fully franked dividend. Each one has not only grown its profits, but has also grown its dividend. One increased it by a whopping 33%, while another trades on a grossed up (fully franked) dividend yield of almost 7%.

The names of these Top 3 ASX Blue Chips are included in this specially prepared free report. But you will have to hurry. Depending on demand – and how quickly the share prices of these companies moves – we may be forced to remove this report.

Click here to claim your free report.

Motley Fool contributor James Mickleboro has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

FREE REPORT: Five Cheap and Good Stocks to Buy now…

Our Motley Fool experts have FREE report, detailing 5 dirt cheap shares that you can buy today.

One stock is an Australian internet darling with a rock solid reputation and an exciting new business line that promises years (or even decades) of growth… while trading at an ultra-low price…

Another is a diversified conglomerate trading near a 52-week low all while offering a 2.7% fully franked yield…

Plus 3 more cheap bets that could position you to profit over the next 12 months!

See for yourself now. Simply click the link below to scoop up your FREE copy and discover all 5 shares. But you will want to hurry – this free report is available for a brief time only.